The "Non-Opioids Prevent Addiction in the Nation for Veterans Act," or NOPAIN for Veterans Act , aims to ensure veterans have access to non-opioid pain management options. It mandates the Secretary of Veterans Affairs to include specific FDA-approved non-opioid pain management drugs or biological products in the Department's national formulary. These products are defined as those approved to reduce postoperative pain, produce postsurgical or regional analgesia, or treat acute pain, without acting upon the body's opioid receptors. The bill requires their inclusion in the formulary within one year of eligibility for certain Medicare payments or 18 months after FDA approval, whichever comes first. The Secretary must implement these amendments within 90 days of the Act's enactment, with a restriction that funds from the Cost of War Toxic Exposures Fund cannot be used.